Janis Naeve joined Cota in 2022. Prior to Cota, Janis was at Amgen, Inc. since 2005 where she was instrumental in establishing the corporate venture group, Amgen Ventures. During that time she led a team that invested in innovative companies developing drug discovery platforms and therapeutics.

More recently Amgen Ventures’ investment portfolio also encompassed companies in digital health, healthcare IT, and advanced data analytics such as AI and machine learning. Janis served on the Caltech Accelerator Fund Committee, the Silicon Valley Bank Healthcare Advisory Committee, the KidneyX Accelerator, and the Advisory Council of Incubator Coalition. Janis was named 2021’s Fiercest Women in Life Sciences by Fierce Pharma. 

Janis has a B.S. in Microbiology from Cal Poly Pomona, a Ph.D. in Experimental Pathology from University of Southern California, and completed a post-doctoral fellowship in Neurobiology at Caltech.